Pharmaceutical Industry: Sludge and Wastewater Management
In the pharmaceutical industry, wastewater management requires extremely high levels of control. Water is used throughout numerous production stages, including extraction, washing, manufacturing, cooling, and equipment sanitization. In addition, the presence of organic substances, chemical residues, and suspended solids makes treatment particularly challenging.
For many pharmaceutical facilities, wastewater treatment is therefore an integral part of both production continuity and regulatory compliance.
Wastewater generated by the pharmaceutical industry can vary significantly depending on the type of production process. Some facilities handle streams with high organic loads, while others must manage effluents containing solvents, active ingredients, or residues resulting from the processing of natural products.
This variability requires a flexible approach capable of adapting to different operating conditions. Sludge management also demands special attention, as the high concentration of organic substances can affect dewatering performance and overall process stability.
In pharmaceutical plants, safety concerns involve both treatment quality and equipment reliability.
Automated and user-friendly systems help reduce the risk of operational issues while simplifying day-to-day management. The ability to monitor process parameters and maintain stable operating conditions contributes to improved reliability and traceability.
One of the most common requirements in the pharmaceutical sector is reducing the volume of generated sludge.
Effective dewatering decreases the amount of material that must be transported and disposed of, improving overall plant management and reducing operating costs associated with sludge handling.
Among the technologies commonly used in these applications are dewatering systems such as MONOBELT® and SCRUPRESS®, developed to operate continuously and automatically, even when dealing with variable sludge characteristics.
In some pharmaceutical facilities, microfiltration is used to reduce suspended solids and improve treated water quality.
Systems such as SCRUFILTER® help remove fine suspended solids from the effluent and contribute to reducing parameters such as COD and BOD5. Microfiltration can also support downstream treatment processes, including UV disinfection, by improving the final quality of the treated water.
Over the years, Teknofanghi has developed solutions for numerous industrial wastewater treatment plants, including pharmaceutical facilities characterized by complex operational requirements, such as electrical control panels designed for full integration with the plant’s main control system.
One case study in the pharmaceutical sector involved a facility dedicated to the extraction of active ingredients from natural products, where an existing system could no longer provide satisfactory results due to sludge variability. Following sludge analysis and performance assessments, a treatment line incorporating MONOBELT® and POLYDILUTION® technology was installed, improving sludge volume reduction and overall plant operation.
In the pharmaceutical industry, wastewater management requires reliable treatment systems. Dewatering, polymer preparation, and microfiltration technologies help improve treatment performance while making sludge and water resource management more efficient.
We support the design of industrial wastewater treatment systems and can assist in developing solutions tailored to the production requirements of the pharmaceutical sector.